复方茵陈注射液处方中增溶剂的选择  被引量:2

Solubilizer Selection of Compound Yinchen Injection Prescription

在线阅读下载全文

作  者:李正明[1] 袁海龙[1] 张诗龙[1] 周燕萍[1] 易毛[1] 张瑞新[1] 吴素体[1] 

机构地区:[1]解放军第302医院,北京100039

出  处:《中国药房》2013年第7期611-613,共3页China Pharmacy

摘  要:目的:选择增溶效果好而不良反应少的药用辅料。方法:分别采用泊洛沙姆188、吐温80作为增溶剂制备复方茵陈注射液,检查药物微粒数量、栀子苷含量、药液pH值、溶血与凝聚等指标变化。结果:2种复方茵陈注射液的栀子苷含量、pH值、微粒数、溶血与凝聚指标均合格。结论:泊洛沙姆188与吐温80具有同等增溶效果,可选择泊洛沙姆作为新一代增溶辅料。OBJECTIVE: To select pharmaceutical adjuvant with sound solubilizing effect and little ADR. METHODS: Com- pound yinchen injection was prepared with poloxamer-188 and tween-80 as solubilizer. The number of drug microparticle, the con- tent of jasminoidin, pH value of drug solution, hemolysis and coacervation were determined. RESULTS: The content of jasminoi- din, pH value, the number of drug microparticle, hemolysis and coacervation of 2 kinds of Compound yinchen injection were all qualified. CONCLUSION: Poloxamer-188 has the same solubilizing effects as tween-80. Poloxamer-188 is an appropriate choice in the new generation of solubilizing adjuvant.

关 键 词:泊洛沙姆188 吐温80 复方茵陈注射液 

分 类 号:R284.2[医药卫生—中药学] R283.61[医药卫生—中医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象